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Mutation in NSUN2, which Encodes an
RNA Methyltransferase, Causes Autosomal-
Recessive Intellectual Disability
Muzammil Ahmad Khan,1,2 Muhammad Arshad Rafiq,1 Abdul Noor,1 Shobbir Hussain,3
Joana V. Flores,3 Verena Rupp,4 Akshita K. Vincent,1 Roland Malli,5 Ghazanfar Ali,2,6 Falak Sher Khan,2
Gisele E. Ishak,7 Dan Doherty,8 Rosanna Weksberg,9 Muhammad Ayub,10,11 Christian Windpassinger,1,4
Shahnaz Ibrahim,12 Michaela Frye,3 Muhammad Ansar,2 and John B. Vincent1,13,*
Causes of autosomal-recessive intellectual disability (ID) have, until very recently, been under researched because of the high degree of
genetic heterogeneity. However, now that genome-wide approaches can be applied to single multiplex consanguineous families, the
identification of genes harboring disease-causing mutations by autozygosity mapping is expanding rapidly. Here, we have mapped
a disease locus in a consanguineous Pakistani family affected by ID and distal myopathy. We genotyped family members on genome-
wide SNP microarrays and used the data to determine a single 2.5 Mb homozygosity-by-descent (HBD) locus in region 5p15.32–
p15.31; we identified the missense change c.2035G>A (p.Gly679Arg) at a conserved residue within NSUN2. This gene encodes a meth-
yltransferase that catalyzes formation of 5-methylcytosine at C34 of tRNA-leu(CAA) and plays a role in spindle assembly during mitosis
as well as chromosome segregation. In mouse brains, we show that NSUN2 localizes to the nucleolus of Purkinje cells in the cerebellum.
The effects of the mutation were confirmed by the transfection of wild-type and mutant constructs into cells and subsequent immuno-
histochemistry. We show that mutation to arginine at this residue causes NSUN2 to fail to localize within the nucleolus. The ID
combined with a unique profile of comorbid features presented here makes this an important genetic discovery, and the involvement
of NSUN2 highlights the role of RNA methyltransferase in human neurocognitive development.Intellectual disability (ID), also called mental retardation
(MR), is a neurodevelopmental disorder that can have
a devastating impact on the affected individuals and their
families. It is believed to occur at a frequency of ~1%–3%
within the population1 and might often be caused by
abnormalities at the genetic level.2,3 ID might present as
the sole clinical feature (nonsyndromic [MIM 249500])
or might be present with additional clinical or dysmorpho-
logical features (syndromic).
We ascertained a consanguineous family from a farming
community in the Khairpur district within the province
of Sindh in Pakistan, where the first-cousin parents had
seven children (three of the five female siblings are affected)
(Figure 1). Amale cousin, offspring of themother’s brother,
was also reported to be affected butwas not available for the
study. Appropriate informed consent was obtained for all
study participants, including unrelated healthy Pakistani
controls and nonsyndromic ID (NSID)-affected individuals
of European descent, and approval was obtained from the
institutional research ethics boards at Quaid-i-Azam
University and theCentre forAddictionandMentalHealth.
The affected family members were assessed by a consultant
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tion Disorders (DISCO6) were used as a framework for
obtaining information about early development, schooling
and academic achievement, current level of social func-
tioning and adjustment, and support and help required
for different activities of daily living. On the basis of this
information, all three affected individuals, whose intelli-
gence quotients (IQs) ranged from40 to 50, were diagnosed
with moderate ID. No features of autism were noted.
Neurological assessment was performed by a consultant
neurologist. The oldest female (II:3) had significant delay
to her development, walking, and talking at 5 years of
age. Her speech was limited to just a few words and was
dysarthric. Sensory examination and fundoscopy were
not possible because she was not cooperative. The indi-
vidual had a long face and a somewhat long and pointed
nose and chin. Height and weight were below the fifth
percentile. Her fingers were tapering, but no hyperextensi-
bility was noted. Muscle tone was increased in all limbs
(power grade 5), reflexes were brisk, and plantars were
equivocal. Other features observed are shown in Table 1.
She is toilet trained, can feed and dress and undress herself,
and can help with household chores.entre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada;
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Figure 1. Pedigree, Mapping, and Mutation Screening for Family MR14
(A) Pedigree of family MR14 from the Khairpur district. Filled circles indicate affected girls.
(B) HomozygosityMapper analysis4 of microarray SNP data: Genome-wide significant regions of homozygosity-by-descent (HBD) are
seen only on 5p and 14q. The 14q locus was excluded because one of the unaffected siblings was also homozygous at this locus, whereas
the unaffected sibling was genotyped as heterozygous at the 5p locus.
(C) Ideogrammatic representation of the critical autozygous or HBD locus in region 5p15.31, as determined from this study and in rela-
tion to the MRT5 locus identified by Najmabadi et al.5
(D) The c.2035G>A substitution encoding the p.Gly679Arg change in a heterozygous carrier and an affected homozygote.
(E) ClustalWalignment of NSUN2 across multiple species showing conservation of the p.Gly679 residue in vertebrates and also in non-
vertebrate animal species.The second girl (II:4) also had significant delay; she
talked at 4 years of age, but her age of walking was less de-
layed. Her speech is also limited and dysarthric, and she is
unable to recall her name when asked. Like her older sister,
she also had a long andpointed face andwas below the fifth
percentile for height andweight.Muscle tonewas increased
in all limbs, reflexeswerebrisk, andplantarswere equivocal.
Other features observed are shown in Table 1. She is toilet
trained and can feed and dress and undress herself,
but she is unable to perform household chores. The coordi-
nation and sensory exam was grossly normal.The AmThe third girl (II:5) walked at 5 years of age but had no
speech at the age of examination (6 years of age). Head
and body measurements were below the fifth percentile.
Unlike II:3 and II:4, her gait and tone were normal, and
her reflexes were brisk with unsustained clonus. A fundus
examination could not be performed, but another
cranial-nerve examination and a systemic examination
were normal. Other features observed are shown in Table 1.
Computed tomography of the brain was performed
for two affected individuals, and it showed normal
ventricles and cerebral volume and was generally normal.erican Journal of Human Genetics 90, 856–863, May 4, 2012 857
Table 1. Anthropometric Measures and Clinical Details for Affected Family Members
Individual
II:3 II:4 II:5
Sex female female female
Age (years) 14 13 6
IQ 40–50 40–50 40–50
OFC (cm) 50 49 46
Height (cm) 152 136 NK
Weight (kg) 32 26.3 NK
LDH (IU/l) 447a NK 463a
CPK (IU/l) 294b NK 60b
Epilepsy – – –
Gait broad broad normal
Feet and/or toes bilateral pes cavus and tight
left Achilles
left foot pes cavus, bilateral equinus position
and tight Achilles, and hyperseparation
between first and second toes
partial bilateral syndactyly
of the fourth and fifth toes
Eyes right-eye strabismus fundoscopy, eye movement, and pupillary
response are normal
intermittent esotropia and
fine horizontal nystagmus
Menses no (Tanner stage 3) yes (Tanner stage 4) no
Pelvic ultrasound small midline uterus, thin endometrium,
and ovaries were not visible
NK NK
The following abbreviations are used: IQ, intelligence quotient; OFC, occipitofrontal circumference; NK, not known or not measured; LDH, lactose dehyrogenase;
CPK, creatine phosphokinase; F, female; and NK, not known or not measured. The comparison of clinical features between this family and the Iranian and Kurdish
families described in Abbasi-Moheb et al. is shown in Table 1 in Abbasi-Moheb et al.7 Photographs of affected individuals are shown in Figure S1.
aReference level is 122–234 IU/l.
bReference level is 34–145 IU/l.Gray- and white-matter differentiation was preserved, and
posterior fossa was unremarkable. Whole-blood count was
within the normal range. However, creatine phosphoki-
nase (CPK) and lactose dehydrogenase (LDH) levels were
measured in two individuals (II:3 and II:4) and indicated
that both had elevated levels of LDH (447 and 463 IU/l,
respectively; the reference level is 122–234 IU/L) and that
only the older sister (II:3) had elevated levels of CPK.
Photographs of all affected individuals were assessed for
dysmorphic features by an experienced clinical geneticist
and are shown in Figure S1, available online. The clinical
examination of affected individuals is summarized in
Table 1. Overall, the general phenotype is of moderate
ID, small head and body size, signs of distal neuropathy
as indicated by pes cavus, broad gait, and tight Achilles
tendons; however, nerve-conductance velocities, wave
latencies, and amplitude were apparently normal. Other
variable features include a long nose and face, hypoplastic
nails, partial syndactyly of the fourth and fifth toes, hyper-
separation between the first and second toes, and absent or
atrophied ovaries.
Genomic DNA was extracted from peripheral-blood
leukocytes by standard methods. We used the Affymetrix
GeneChip Mapping 500K array to analyze DNA samples
of three affected individuals and one unaffected individual
by using just the NspI chip; this allowed us to genotype858 The American Journal of Human Genetics 90, 856–863, May 4, 2~260,000 SNPs. Microarray analysis was performed at the
London Regional Genomics Centre at the University of
Western Ontario. Homozygosity mapping, performed
with the dChip analyzer,8–10 identified a ~5 Mb homozy-
gosity-by-descent (HBD) locus within region 5p15.3.
This locus is flanked by SNPs rs2259 (2.635 Mb) and
rs2914296 (7.657 Mb) and overlaps another locus (desig-
nated MRT5) previously identified in an Iranian family as
harboring a nonsyndromic autosomal-recessive ID (NS-
ARID)-associated mutation. However, no gene harboring
disease-causing mutations has yet been reported for this
locus.5 The MRT5 locus was defined by SNP markers
rs1824938 (5.092 Mb) and rs60701 (10.734 Mb). Thus,
the common region shared between our Pakistani family
and the Iranian family was from rs1824938 (5.092 Mb)
to rs2914296 (7.657 Mb)—a 2.565 Mb critical region.
Additional genotype data frommicrosatellite markers on
5p also verified this, and linkage analysis gave a maximum
LOD score of 2.77 for marker D5S406 (see Table 2).
All known coding genes within this 2.565 Mb critical
region were screened for mutations by sequencing. We
identified a homozygous substitution, c.2035G>A (RefSeq
NM_017755.5) (GRCh37/hg19 chr5: 6,600,308C>T),
within exon 19 of NSUN2 (MIM 610916), which is one of
the eight known genes within this locus. This substitution
would result in the missense change p.Gly679Arg. This012
Table 2. Two-Point Linkage Analysis for Markers across Chromosome 5p
Markers Position (cM) Physical Position (Mb)
LOD Score at Recombination Fraction, q
0.00 0.05 0.2 0.4
D5S1981 1.7200 1.155 0.4327 0.3972 0.2597 0.0585
D5S406 11.8500 4.994 2.7729 2.4887 1.6231 0.5141
D5S2505 14.3000 5.817 1.6695 1.4721 0.8628 0.1437
D5S580 17.8700 8.141 0.4327 0.3972 0.2597 0.0585
D5S630 19.6710 9.561 0.4327 0.3972 0.2597 0.0585
The EasyLINKAGE program26 was used. The physical positions are according to UCSC Feb 2009 (GRCh37/hg19) assembly. For reference, the common homozy-
gosity-by-descent (HBD) locus for the Pakistani family and the Iranian family5 extends from SNPs rs1824938 (5.092 Mb) to rs2914296 (7.657 Mb), and NSUN2 is
located between 6.599 and 6.633 Mb.
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Figure 2. Cellular Localization of WT and Mutant NSUN2 in
Human Breast Cancer Cell Line HCC1954
WT (A) and mutant (B) NSUN2 constructs in the vector pcDNA-
Myc transfected into the human breast cancer cell line
HCC1954. A. WT NSUN2 (A) but not mutant NSUN2 (B) protein
colocalizes with nucleophosmin, a nucleolar marker. The scale
bar represents 20 mm.
(C) Costaining for endogenous NSUN2 confirms exclusion of
mutant NSUN2 (Myc-labeled) from the nucleoli. Arrows indicate
nucleoli (A–C). Costaining with DAPI shows nuclear localization.
The scale bar represents 20 mm.substitution is not a known SNP in any SNP databases
and is not found in the 1000 Genomes Project or the
National Heart, Lung, and Blood Institute Exome Sequenc-
ing Project (ESP5400 release; 5,379 subjects). We also
confirmed this by sequencing over 200 Pakistani control
individuals. In addition to c.2035G>A, a 250 bp insertion
just after exon 9 was also identified in the members of the
family. However, after genotyping was performed for
Pakistani controls by PCR amplification across exon 19, it
was apparent that this is a relatively common polymor-
phism. All primer sequences are available upon request.
The 679Gly residue is highly conserved across evolution
of the animal kingdom (Figure 1E), and in silico analyses
using PolyPhen and SIFT identify the substitution as being
‘‘possibly damaging’’ and ‘‘not tolerated,’’ respectively. A
screening set of 45 NSID individuals of European descent
(negative for mutations in FMR1 and MECP2) did not
show any mutations in NSUN2.
NSUN2 encodes a methyltransferase that catalyzes the
intron-dependent formation of 5-methylcytosine at C34 of
tRNA-leu(CAA).11 It also functions in spindle assembly
during mitosis as well as chromosome segregation.12 Pre-
vious work on constructs of the mouse homolog Nsun2
carrying themissensechangep.Lys190Methaveshownabla-
tion of methyltransferase catalytic activity.12 p.Lys190Met
has not been identified in any human subjects.
Using a cDNA clone for NSUN2 in the pcDNA3.1-Myc
vector, we performed site-directed mutagenesis to generate
the c.2035G>A (p.Gly679Arg) mutation. Wild-type (WT)
and mutant constructs were transfected into the human
breast cancer cell line HCC1954 and also into COS7
(monkey kidney) cells. 24 hr later, we stained cells with
antibodies against theMyc epitope in order to detect trans-
fected proteins. Although WT NSUN2 was detected in the
nucleus and nucleolus of transfected HCC1954 cells
(Figure 2A), the p.Gly679Arg mutant failed to localize to
the nucleoli in most transfected cells (Figures 2B and 2C).
We used antibodies against the nucleolar marker protein
nucleophosmin (NPM1) to confirm colocalization in the
nucleoli (Figures 2A and 2B), and colabeling for endoge-
nous NSUN2 confirmed the nucleolar localization of
endogenous NSUN2 (Figure 2C).The AmInstead of being localized to the nucleoli, the
p.Gly679Arg NSUN2 mutant accumulated in the nucleo-
plasm in 80% of transfected cells (Figures 3A, 3B, and
3D). In fewer than 10% of transfected cells, it was observed
that the p.Gly679Arg mutant NSUN2 did localize to the
nucleoli and, at the same time, showed intense staining
within the cytoplasm (Figures 3A, 3C,and 3D). Also of
note was the fact that the mutant protein seemed to be
largely excluded from the nucleoplasm in these cells
(Figure 3C). Similar results were also seen for the COS7erican Journal of Human Genetics 90, 856–863, May 4, 2012 859
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Figure 3. Cytoplasmic, Nuclear, and Nucleolar Localization of
WT and Mutant NSUN2 in HCC1954 and HeLa Cells
(A) Immunostaining shows nucleolar localization of WT NSUN2
in HCC1954 cells. Costaining with DAPI shows nuclear localiza-
tion.
(B and C) Cellular localization of NSUN2 carrying the 679Arg
variant (p.Gly679Arg) in the nucleoplasm (B) and cytoplasm (C).
Costaining with DAPI shows nuclear localization.
(D) Quantification of cellular localizations shown in (A–C). Error
bars represent the standard deviation.
(E) Nucleolar localization of GFP-tagged WT NSUN2 in HeLa cells.
White arrow heads indicate nucleoli.
(F) Nuclear and cytoplasmic localization in 679Arg mutant NSUN2
(p.Gly679Arg). White arrow heads indicate nucleoli.
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Figure 4. Localization of EndogenousWTNsun2 inMouse Cere-
bellum
(A) Sections of mouse cerebellum labeled with an antibody against
NSUN2. The following abbreviations are used: NF, nerve fibers;
GCL, granule cell layer; and ML, molecular layer.
(B) A higher magnification of an insert in (A) shows NSUN2 in
Purkinje cells.
(C) Sections of the cerebellum labeled with L7/Pcp-2, a marker for
Purkinje cells.
(D) Colocalization of NSUN2 with nucleophosmin (Npm1) in the
nucleoli of Purkinje cells. Nuclei are counter stained with DAPI.cells—the mutant NSUN2 localized mainly in the cyto-
plasm. We conclude that the substitution of glycine to
arginine at position 679 impairs the proper cellular locali-
zation of NSUN2.
In parallel, WT and mutant cDNA constructs were
generated in the pcDNA3.1 vector with GFP tag and
were transfected into the human endothelial cell line
EA.hy 926 (from the umbilical vein). In EA.hy 926 cells,
WT NSUN2-GFP colocalizes with the nucleophosmin 1
antibody (Santa Cruz) in the nucleoli, whereas the
p.Gly679Arg mutant NSUN2-GFP remains in the nucleo-
plasm (data not shown).860 The American Journal of Human Genetics 90, 856–863, May 4, 2In order to gain some insight into NSUN2 function in
the brain, we sought to identify specific mouse neural
cell types that displayed NSUN2 localization. To this end,
we dissected the cortical and cerebellar regions from whole
brains of 3-month-old mice. Tissue was fixed for 24 hr in
paraformaldehyde, paraffin sections were taken, antigen
retrieval was performed, and sections were stained with
affinity-purified NSUN2 antibody (Covalab). Although
we were able to observe NSUN2 staining sporadically in
some cortical and brain-stem neurons (Figure S2), by far
the most striking localization was observed in Purkinje
cells of the cerebellum (Figures 4A and 4B). Higher-magni-
fication imaging revealed that NSUN2 localizes to the
nucleoli of Purkinje cells and that these nucleoli were often
located between or adjacent to dense heterochromatic
regions (Figures 4C and 4D). Interestingly, in addition to
ID, NSUN2-mutation-positive individuals in the current
study display features such as poor speech (dysarthria)
and broad gait, which have previously been associated
with cerebellar defects. It is therefore likely that the disrup-
tion of NSUN2 function in Prukinje cells contributes to the
phenotype of these individuals. Given the developmental
phenotype in the Pakistani family, the fact that we have
also demonstrated NSUN2 expression in the cerebellum
of 3-day-old mice by using LacZ staining (Figure S2)
suggests that NSUN2 is expressed in these tissues during
development as well as adulthood. It is also worth noting
that, although ID is not usually associated with cerebellar
defects (it is associated much more commonly with012
cortical defects), there are several reports that describe ID
in association with cerebellar dysfunction.13–16 Purkinje
cells are a class of GABAergic neuron, and, at the heart of
the cerebellar circuitry, they receive more synaptic inputs
than any other cell type in the brain. It is interesting that
the NSUN2 missense variant identified in the ID-affected
family fails to localize to the nucleolus because it hints at
a mechanism by which proper Purkinje cell function
might be inhibited as a result of aberrant exclusion of
NSUN2 from the nucleoli of these cells. In more recent
years, the nucleolus has become established as amultifunc-
tional entity rather than simply a ribosomal RNA-process-
ing center as previously envisioned.17 A better under-
standing of the nucleolar functioning of NSUN2 in
addition to the identification of its methylation substrates
will no doubt shed light on the cellular mechanisms dis-
rupted in NSUN2-mutation-positive individuals.
In a recent study of Nsun2 in mice, a knockout that leads
to the ablation of Nsun2 through the deletion of exon 8
was generated.18 Heterozygous mice appeared normal
and had no visible phenotype. Nsun2/ mice were also
viable, and the gross phenotype indicated weight loss
(~30% reduction at 3 months old) and partial alopecia at
~10 months old, suggesting a role for NSUN2 in skin
homeostasis. Nsun2/ males were sterile. The small size
of theNsun2/micemight be consistent with the reduced
growth in the affected individuals from the Khairpur
family. Heights of the affected girls (~tenth percentile for
II:3 and first percentile for II:4) are below the mean for
Pakistani girls (from the United Kingdom19). Weight is
strikingly low—both II:3 and II:4 are below the first percen-
tile (according to standard growth charts19). Interestingly,
in one of the affected individuals from the Khairpur family,
ovaries were either atrophied or absent. However, no
information on sexual development or sterility in affected
male family members was available. Studies of an Nsun2-
knockout mouse generated by the European Conditional
Mouse Mutagenesis program (EUCOMM) has been re-
ported by the Wellcome Trust Sanger Institute, and some
preliminary data are available online from the Mouse
Resources group. This mouse has a deletion of exon 6,
resulting in a frameshift. Neurobehavioral and neurocog-
nitive analysis of heterozygous and homozygous mice via
hot-plate tests, open-field tests, and a modified SHIRPA
test20 showed no overall difference between these mice
and control mice. However, male homozygotes are re-
ported as hyperactive in calorimetric studies. Male homo-
zygous mutant mice showed significantly reduced forepaw
grip strength, and abnormal humerus morphology is re-
ported for both sexes. Body size was decreased for male
and female homozygotes, and abnormal skull and teeth
morphology was reported. An eye phenotype, in which
the cornea was abnormal and the lens showed increased
opacity, was also present in homozygotes. Fertility and
fecundity are also reported as abnormal. These data were
provided by and can be obtained from the Mouse
Resources group at the Wellcome Trust Sanger Institute.The AmMore in-depth neurocognitive assessments would be
particularly useful on this model. It might also be impor-
tant to compare future clinical developments in the family
with those of the knockout mouse, e.g., whether signs of
alopecia develop later on.
NSUN2 is now the third RNA-methyltransferase-encod-
ing gene to be linked to ID. Previously, FTSJ1was identified
in X-linked nonsyndromic ID,21,22 and very recently,
TRMT1 was identified as a cause of autosomal-recessive
ID (ARID).23 Coexpression data from zebrafish, fruit flies,
and yeast have linked NSUN2 to both TRMT1 (STRING;
coexpression score¼ 0.877) and FTSJ1. Coimmunoprecipi-
tation assays have also shown protein-protein interactions
between NSUN2 and FTSJ1 (IntAct interaction database).
Although NSUN2 was initially thought to have a very
narrow range of tRNA targets, this range is broadening
and is currently also thought to include mRNAs.24 A role
for NSUN2 in DNA methylation has not been excluded
but seems unlikely given its nucleolar localization.
Thus, our findings strongly support a role for NSUN2
mutations in ARID, for which additional clinical symp-
toms are apparent. A publication on gene mapping in
Iranian families has also identified this region,5,25 and in
this issue of AJHG, an article from this group also reports
the identification of truncating mutations in the same
gene, NSUN2, in one Kurdish and several Iranian consan-
guineous ARID-affected families.7 Thus, this is one of the
few ARID-associated genes for which there is validation
in several independent families and from more than one
ethnic group or geographic location. Given the similarities
in the phenotypes of the families from this study and that
of Abbasi-Moheb et al.,7 we speculate that the missense
mutation reported here has a similar effect to that of the
truncating mutations in NSUN2 and that Gly679Arg
mainly results in a loss of function due to failure of the
protein to localize to the correct cellular organelles; this
failure thus results in ID. We speculate further that the
myopathy reported in the Pakistani family was not noted
in either the Iranian or the Kurdish families affected by
NSUN2 truncating mutations and might result from
a gain of function due to accumulation of NSUN2 in the
nucleoplasm and cytoplasm.Supplemental Data
Supplemental Data include two figures and can be found with this
article online at http://www.cell.com/AJHG/.Acknowledgments
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